Literature DB >> 15155640

Suppression of serum antibody responses by pertussis toxin after respiratory tract colonization by Bordetella pertussis and identification of an immunodominant lipoprotein.

Nicholas H Carbonetti1, Galina V Artamonova, Charlotte Andreasen, Edward Dudley, R Michael Mays, Zoe E V Worthington.   

Abstract

Pertussis toxin (PT), a virulence factor secreted by Bordetella pertussis, contributes to respiratory tract infection and disease caused by this pathogen. By comparing a wild-type (WT) B. pertussis strain to a mutant strain with an in-frame deletion of the ptx genes encoding PT (DeltaPT), we recently found that the lack of PT confers a significant defect in respiratory tract colonization in mice after intranasal inoculation. In this study, we analyzed serum antibody responses in mice infected with the WT or DeltaPT strain and found that infection with the DeltaPT strain elicited greater responses to several B. pertussis antigens than did infection with the WT, despite the lower colonization level achieved by the DeltaPT strain. The same enhanced antibody response was observed after infection with a strain expressing an enzymatically inactive PT; but this response was not observed after infection with B. pertussis mutant strains lacking filamentous hemagglutinin or adenylate cyclase toxin, nor when purified PT was administered with the DeltaPT inoculum, indicating a specific role for PT activity in this immunosuppressive effect. In particular, there were consistent strong serum antibody responses to one or more low-molecular-weight antigens after infection with the DeltaPT strain. These antigens were Bvg independent, membrane localized, and also expressed by the closely related pathogens Bordetella parapertussis and Bordetella bronchiseptica. Two-dimensional gel electrophoresis and mass spectrometry were used to identify one of the immunodominant low-molecular-weight antigens as a protein with significant sequence homology to peptidoglycan-associated lipoprotein in several other gram-negative bacterial species. However, a serum antibody response to this protein alone did not protect mice against respiratory tract infection by B. pertussis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15155640      PMCID: PMC415701          DOI: 10.1128/IAI.72.6.3350-3358.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  48 in total

1.  Interaction of Bordetella pertussis with mast cells, modulation of cytokine secretion by pertussis toxin.

Authors:  N Mielcarek; E H Hörnquist; B R Johansson; C Locht; S N Abraham; J Holmgren
Journal:  Cell Microbiol       Date:  2001-03       Impact factor: 3.715

2.  Adenylate cyclase toxin is critical for colonization and pertussis toxin is critical for lethal infection by Bordetella pertussis in infant mice.

Authors:  M S Goodwin; A A Weiss
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

3.  The excC gene of Escherichia coli K-12 required for cell envelope integrity encodes the peptidoglycan-associated lipoprotein (PAL).

Authors:  J C Lazzaroni; R Portalier
Journal:  Mol Microbiol       Date:  1992-03       Impact factor: 3.501

4.  Pertussis toxin analog with reduced enzymatic and biological activities is a protective immunogen.

Authors:  A Kimura; K T Mountzouros; P A Schad; W Cieplak; J L Cowell
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

5.  Pertussis in hospitalized children.

Authors:  V N Gan; T V Murphy
Journal:  Am J Dis Child       Date:  1990-10

6.  Role of ADP-ribosyltransferase activity of pertussis toxin in toxin-adhesin redundancy with filamentous hemagglutinin during Bordetella pertussis infection.

Authors:  S Alonso; K Pethe; N Mielcarek; D Raze; C Locht
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

7.  The crystal structure of pertussis toxin.

Authors:  P E Stein; A Boodhoo; G D Armstrong; S A Cockle; M H Klein; R J Read
Journal:  Structure       Date:  1994-01-15       Impact factor: 5.006

8.  Pertussis toxin and the adenylate cyclase toxin from Bordetella pertussis activate human monocyte-derived dendritic cells and dominantly inhibit cytokine production through a cAMP-dependent pathway.

Authors:  Kenneth C Bagley; Sayed F Abdelwahab; Robert G Tuskan; Timothy R Fouts; George K Lewis
Journal:  J Leukoc Biol       Date:  2002-11       Impact factor: 4.962

9.  Bacterial peptidoglycan-associated lipoprotein is released into the bloodstream in gram-negative sepsis and causes inflammation and death in mice.

Authors:  Judith Hellman; Jesse D Roberts; Megan M Tehan; Jennifer E Allaire; H Shaw Warren
Journal:  J Biol Chem       Date:  2002-02-05       Impact factor: 5.157

10.  Adjuvant action of cholera toxin and pertussis toxin in the induction of IgA antibody response to orally administered antigen.

Authors:  A D Wilson; A Robinson; L Irons; C R Stokes
Journal:  Vaccine       Date:  1993       Impact factor: 3.641

View more
  30 in total

1.  Pertussis toxin inhibits neutrophil recruitment to delay antibody-mediated clearance of Bordetella pertussis.

Authors:  Girish S Kirimanjeswara; Luis M Agosto; Mary J Kennett; Ottar N Bjornstad; Eric T Harvill
Journal:  J Clin Invest       Date:  2005-11-17       Impact factor: 14.808

2.  Interleukin-1 receptor signaling is required to overcome the effects of pertussis toxin and for efficient infection- or vaccination-induced immunity against Bordetella pertussis.

Authors:  Xuqing Zhang; Sara E Hester; Mary J Kennett; Alexia T Karanikas; Liron Bendor; David E Place; Eric T Harvill
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

3.  Characterization of serological responses to pertussis.

Authors:  Mineo Watanabe; Beverly Connelly; Alison A Weiss
Journal:  Clin Vaccine Immunol       Date:  2006-03

4.  Epithelial anion transporter pendrin contributes to inflammatory lung pathology in mouse models of Bordetella pertussis infection.

Authors:  Karen M Scanlon; Yael Gau; Jingsong Zhu; Ciaran Skerry; Susan M Wall; Manoocher Soleimani; Nicholas H Carbonetti
Journal:  Infect Immun       Date:  2014-07-28       Impact factor: 3.441

Review 5.  Contribution of pertussis toxin to the pathogenesis of pertussis disease.

Authors:  Nicholas H Carbonetti
Journal:  Pathog Dis       Date:  2015-09-21       Impact factor: 3.166

6.  Pertussis toxin exacerbates and prolongs airway inflammatory responses during Bordetella pertussis infection.

Authors:  Carey E Connelly; Yezhou Sun; Nicholas H Carbonetti
Journal:  Infect Immun       Date:  2012-10-01       Impact factor: 3.441

7.  Enhancement of Bordetella parapertussis infection by Bordetella pertussis in mixed infection of the respiratory tract.

Authors:  Zoë E V Worthington; Nico Van Rooijen; Nicholas H Carbonetti
Journal:  FEMS Immunol Med Microbiol       Date:  2011-07-29

8.  Role of Major Toxin Virulence Factors in Pertussis Infection and Disease Pathogenesis.

Authors:  Karen Scanlon; Ciaran Skerry; Nicholas Carbonetti
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

9.  Pertussis toxin inhibits early chemokine production to delay neutrophil recruitment in response to Bordetella pertussis respiratory tract infection in mice.

Authors:  Charlotte Andreasen; Nicholas H Carbonetti
Journal:  Infect Immun       Date:  2008-09-02       Impact factor: 3.441

10.  Pertussis toxin stimulates IL-17 production in response to Bordetella pertussis infection in mice.

Authors:  Charlotte Andreasen; Daniel A Powell; Nicholas H Carbonetti
Journal:  PLoS One       Date:  2009-09-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.